EMERGENT BIOSOLUTIONS INC. Payments for Restructuring
EMERGENT BIOSOLUTIONS INC. (EBS) reported Payments for Restructuring of $454.00 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2015-03-09
- EMERGENT BIOSOLUTIONS INC. payments for restructuring for the quarter ending 2013-12-31 was $0.00.
- EMERGENT BIOSOLUTIONS INC. payments for restructuring for fiscal 2014 was $454.00K, a 79.60% decline from fiscal 2013.
- EMERGENT BIOSOLUTIONS INC. payments for restructuring for fiscal 2013 was $2.23M.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|
| 2014-12-31 | $454.00K 10-K · filed 2015-03-09 | ||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $2.23M 10-K · filed 2015-03-09 | |
| 2013-09-30 | $2.23M 10-Q · filed 2013-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |